One-Year Follow-Up Shows Continued Efficacy of Gene Therapy for Duchenne Muscular Dystrophy
The phase 3 EMBARK study assessed the safety and efficacy of delandistrogene moxeparvovec for the treatment of Duchenne muscular dystrophy (DMD). At 1 year...
Regulatory Considerations for the Use of AI in Pharmacy, Managed Care
Artificial intelligence (AI) is transforming a number of industries, including healthcare. A session at the AMCP 2025 Annual Meeting addressed the legal landscape and...
Real-World Model Demonstrates a Way to Improve CVD-Related Care Coordination
Cardiovascular disease (CVD) is a persistent public health challenge, and patients remain at risk of a cardiovascular event despite clinical guidelines aimed at managing...
Socioeconomic Disparities Persist in the Management, Treatment of ATTR-CM
Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is a rare and progressive condition. There are significant diagnostic gaps in the Black community. A session at the AMCP...